(S)-(-)-CARBIDOPA-D3 H2O (RING-D3);(S)-(-)-Carbidopa D3 H2OQ: What is
(S)-(-)-Carbidopa D3 H2O Q: What is the CAS Number of
(S)-(-)-Carbidopa D3 H2O Q: What is the storage condition of
(S)-(-)-Carbidopa D3 H2O Q: What are the applications of
(S)-(-)-Carbidopa D3 H2O;Carbidopa-d
Cas No.
1276197-58-0
分子式
C10H13D3N2O5
分子量
247.26
包装储存
Please store the product under the recommended conditions in the Certificate of Analysis.
Carbidopa-d 3 (monohydrate) is the deuterium labeled Carbidopa monohydrate. Carbidopa ((S)-(-)-Carbidopa) monohydrate, a peripheral decarboxylase inhibitor, can be used for the research of Parkinsons disease. Carbidopa monohydrate is a selective aryl hydrocarbon receptor (AhR) modulator. Carbidopa monohydrate inhibits pancreatic cancer cell and tumor growth[1][2].
体外研究(In Vitro)
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [2]. Safe S. Carbidopa: a selective Ah receptor modulator (SAhRM). Biochem J. 2017;474(22):3763-3765. Published 2017 Nov 6.[3]. Fermaglich J. Treatment of Parkinsons disease wit